Handa Pharmaceuticals, Inc. (TPEX:6620)
Taiwan
· Delayed Price · Currency is TWD 75.60
-0.40 (-0.53%)
Apr 29, 2026, 1:30 PM CST
Handa Pharmaceuticals Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 12,580 | 13,530 | 10,576 | 25,891 | 16,074 | 8,451 | Upgrade
|
| Market Cap Growth | -2.58% | 27.93% | -59.15% | 61.07% | 90.20% | 199.72% | Upgrade
|
| Enterprise Value | 8,924 | 10,965 | 8,085 | 23,747 | 15,869 | 8,249 | Upgrade
|
| Last Close Price | 76.00 | 86.00 | 73.58 | 179.00 | 118.61 | 65.86 | Upgrade
|
| PE Ratio | 15.73 | 18.05 | 22.37 | 35.62 | - | - | Upgrade
|
| PS Ratio | 7.27 | 7.82 | 12.73 | 23.40 | 81.32 | 289.08 | Upgrade
|
| PB Ratio | 2.22 | 2.39 | 3.39 | 9.39 | 22.29 | 18.25 | Upgrade
|
| P/TBV Ratio | 2.57 | 2.77 | 4.89 | 9.52 | 23.46 | 19.80 | Upgrade
|
| P/FCF Ratio | 55.49 | 59.68 | 21.59 | 38.79 | - | - | Upgrade
|
| P/OCF Ratio | 51.64 | 55.54 | 21.25 | 38.74 | - | - | Upgrade
|
| EV/Sales Ratio | 5.16 | 6.34 | 9.73 | 21.47 | 80.28 | 282.15 | Upgrade
|
| EV/EBITDA Ratio | 8.13 | 10.10 | 19.20 | 34.00 | - | - | Upgrade
|
| EV/EBIT Ratio | 9.55 | 11.74 | 19.34 | 34.25 | - | - | Upgrade
|
| EV/FCF Ratio | 39.36 | 48.36 | 16.51 | 35.58 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.04 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | 0.04 | 0.04 | 0.09 | 0.02 | - | - | Upgrade
|
| Debt / FCF Ratio | 0.21 | 0.21 | 0.08 | 0.02 | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.65 | -0.65 | -0.57 | -0.84 | -0.47 | -0.59 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.37 | -3.37 | -4.25 | -3.30 | 4.14 | 1.11 | Upgrade
|
| Net Debt / FCF Ratio | -16.13 | -16.13 | -3.65 | -3.45 | 1.59 | 1.47 | Upgrade
|
| Asset Turnover | 0.37 | 0.37 | 0.26 | 0.58 | 0.31 | 0.05 | Upgrade
|
| Quick Ratio | 36.41 | 36.41 | 8.49 | 12.89 | 11.63 | 10.05 | Upgrade
|
| Current Ratio | 36.60 | 36.60 | 8.72 | 12.96 | 13.07 | 10.57 | Upgrade
|
| Return on Equity (ROE) | 17.08% | 17.08% | 16.10% | 41.81% | -6.76% | -49.43% | Upgrade
|
| Return on Assets (ROA) | 12.51% | 12.51% | 8.07% | 22.64% | -8.54% | -29.36% | Upgrade
|
| Return on Invested Capital (ROIC) | 38.05% | 44.86% | 46.33% | 151.89% | -30.57% | -118.36% | Upgrade
|
| Return on Capital Employed (ROCE) | 16.20% | 16.20% | 13.10% | 24.50% | -11.80% | -54.20% | Upgrade
|
| Earnings Yield | 5.96% | 5.54% | 4.47% | 2.81% | -0.25% | -2.93% | Upgrade
|
| FCF Yield | 1.80% | 1.68% | 4.63% | 2.58% | -1.32% | -2.19% | Upgrade
|
| Dividend Yield | 2.62% | 2.33% | 2.05% | 0.56% | - | - | Upgrade
|
| Payout Ratio | 31.52% | 31.52% | 29.84% | - | - | - | Upgrade
|
| Buyback Yield / Dilution | -10.09% | -10.09% | -4.73% | -7.29% | -6.65% | -1.87% | Upgrade
|
| Total Shareholder Return | -7.46% | -7.76% | -2.68% | -6.73% | -6.65% | -1.87% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.